Osteopontin in Cardiovascular Disease A Potential Therapeutic Target

被引：80
|
作者：
Waller, Alfonso H. [1 ]
Sanchez-Ross, Monica [1 ]
Kaluski, Edo [1 ]
Klapholz, Marc [1 ]
机构：
[1] UMDNJ, New Jersey Med Sch, Div Cardiol, Dept Med, Newark, NJ 07103 USA
来源：
CARDIOLOGY IN REVIEW | 2010年 / 18卷 / 03期
关键词：
osteopontin; myocardial infarction; heart failure; calcification; valvular disease; myocardial remodeling; MICROVASCULAR ENDOTHELIAL-CELLS; LEFT-VENTRICULAR DILATION; ANGIOTENSIN-II; PLASMA OSTEOPONTIN; MYOCARDIAL-INFARCTION; MESSENGER-RNA; ATHEROSCLEROTIC LESIONS; BONE SIALOPROTEIN; CARDIAC FIBROSIS; HEART-FAILURE;
D O I：
10.1097/CRD.0b013e3181cfb646
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Osteopontin (OPN), also known as 44kDa bone phosphoprotein, sialoprotein I, secreted phosphoprotein I, 2ar, uropontin, and early T-lymphocyte activation-1 (Eta-1), is a multifunctional protein. OPN has been found to be expressed in various cell types and species with many physiologic and pathologic functions. OPN has emerged as a potential biomarker and mediator in cardiovascular disease. In this review, we will discuss the roles of OPN in cardiovascular disease, specifically in vascular and valvular heart disease, myocardial infarction and heart failure.
引用
收藏
页码：125 / 131
页数：7
相关论文
共 50 条
  • [1] Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
    Zhu, Qiquan
    Luo, Xu
    Zhang, Jie
    Liu, Yun
    Luo, Hansheng
    Huang, Qin
    Cheng, Yuan
    Xie, Zongyi
    CURRENT DRUG DELIVERY, 2017, 14 (06) : 766 - 772
  • [2] The Potential of Osteopontin as a Therapeutic Target for Human Colorectal Cancer
    Wang Likui
    Wang Hong
    Zhang Shuwen
    You Yuangang
    Wen Yan
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (04) : 652 - 659
  • [3] The Potential of Osteopontin as a Therapeutic Target for Human Colorectal Cancer
    Wang Likui
    Wang Hong
    Zhang Shuwen
    You Yuangang
    Wen Yan
    Journal of Gastrointestinal Surgery, 2011, 15 : 652 - 659
  • [4] CD38: A Potential Therapeutic Target in Cardiovascular Disease
    Wanyun Zuo
    Na Liu
    Yunhong Zeng
    Yaozhong Liu
    Biao Li
    Keke Wu
    Yunbin Xiao
    Qiming Liu
    Cardiovascular Drugs and Therapy, 2021, 35 : 815 - 828
  • [5] The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease
    Muenzel, Thomas
    Daiber, Andreas
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (03) : 217 - 231
  • [6] Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease
    Broekhuizen, Lysette N.
    Mooij, Hans L.
    Kastelein, John J. P.
    Stroes, Erik S. G.
    Vink, Hans
    Nieuwdorp, Max
    CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (01) : 57 - 62
  • [7] The endothelin system and its potential as a therapeutic target in cardiovascular disease
    Gray, GA
    Webb, DJ
    PHARMACOLOGY & THERAPEUTICS, 1996, 72 (02) : 109 - 148
  • [8] Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
    Behbodikhah, Jennifer
    Ahmed, Saba
    Elyasi, Ailin
    Kasselman, Lora J.
    De Leon, Joshua
    Glass, Amy D.
    Reiss, Allison B.
    METABOLITES, 2021, 11 (10)
  • [9] CD38: A Potential Therapeutic Target in Cardiovascular Disease
    Zuo, Wanyun
    Liu, Na
    Zeng, Yunhong
    Liu, Yaozhong
    Li, Biao
    Wu, Keke
    Xiao, Yunbin
    Liu, Qiming
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (04) : 815 - 828
  • [10] Osteopontin: an emerging therapeutic target in uraemic vascular disease
    Zhang, Xin
    Eirin, Alfonso
    Lerman, Amir
    Lerman, Lilach O.
    CARDIOVASCULAR RESEARCH, 2013, 98 (03) : 332 - 333
12345